These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478 [TBL] [Abstract][Full Text] [Related]
6. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481 [TBL] [Abstract][Full Text] [Related]
7. Anemia in patients with hidradenitis suppurativa : A systematic review with meta-analysis. Revankar R; Rojas M; Walsh S; Patel H; Revankar N; Han J; Parameswaran A Arch Dermatol Res; 2023 Aug; 315(6):1639-1648. PubMed ID: 36781458 [TBL] [Abstract][Full Text] [Related]
8. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar. Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis. Jfri A; Nassim D; O'Brien E; Gulliver W; Nikolakis G; Zouboulis CC JAMA Dermatol; 2021 Aug; 157(8):924-931. PubMed ID: 34037678 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers. Delage M; Samimi M; Atlan M; Machet L; Lorette G; Maruani A Acta Derm Venereol; 2011 Mar; 91(2):169-71. PubMed ID: 21384087 [TBL] [Abstract][Full Text] [Related]
14. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa. van Rappard DC; Leenarts MF; Meijerink-van 't Oost L; Mekkes JR J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155 [TBL] [Abstract][Full Text] [Related]
15. High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa. Ghias MH; Johnston AD; Kutner AJ; Micheletti RG; Hosgood HD; Cohen SR J Am Acad Dermatol; 2020 May; 82(5):1094-1101. PubMed ID: 31589948 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy. Shanmugam VK; Mulani S; McNish S; Harris S; Buescher T; Amdur R Int J Dermatol; 2018 Jan; 57(1):62-69. PubMed ID: 29130482 [TBL] [Abstract][Full Text] [Related]
18. Association of Hidradenitis Suppurativa With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Chen WT; Chi CC JAMA Dermatol; 2019 Sep; 155(9):1022-1027. PubMed ID: 31290938 [TBL] [Abstract][Full Text] [Related]
19. The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review. van Rappard DC; Limpens J; Mekkes JR J Dermatolog Treat; 2013 Oct; 24(5):392-404. PubMed ID: 22397574 [TBL] [Abstract][Full Text] [Related]